상세 보기
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 (vol 8, 101588, 2023)
- Kim, M.;
- Lee, J. L.;
- Shin, S. J.;
- Bae, W. K.;
- Lee, H. J.;
- ... Choi, Y. J.;
- 외 7명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 (vol 8, 101588, 2023)
- 저자
- Kim, M.; Lee, J. L.; Shin, S. J.; Bae, W. K.; Lee, H. J.; Byun, J. H.; Choi, Y. J.; Youk, J.; Ock, C. Y.; Kim, S.; Song, H.; Park, K. H.; Keam, B.
- 발행일
- 2024-11
- 유형
- Correction
- 저널명
- ESMO Open
- 권
- 9
- 호
- 11
- 페이지
- 1 ~ 1